Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report

Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report

Here we describe the case of a 51 years old Italian woman with acute lymphoblastic leukemia who underwent to hematopoietic stem cell transplantation (HSCT) during SARS-COV-2 infection. She presented a prolonged COVID-19 successfully treated with dual anti SARS-COV-2 antiviral plus monoclonal antibod...

Полное описание

Библиографические подробности
Главные авторы: Serena Vita, Alessandra D’Abramo, Andrea Coppola, Chiara Farroni, Anna Paola Iori, Francesca Faraglia, Alessandro Sette, Alba Grifoni, Cecilia Lindestam Arlehamn, Michele Bibas, Delia Goletti, Emanuele Nicastri
Формат: Статья
Язык:English
Опубликовано: Frontiers Media S.A. 2024-02-01
Серии:Frontiers in Oncology
Предметы:
immunocompromised
SARS-CoV-2 infection
HSCT
antivirals
prolonged infection
dual antiviral therapy
Online-ссылка:https://www.frontiersin.org/articles/10.3389/fonc.2024.1290614/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1290614/full

Схожие документы